SLC29A1 and leukemia: The current study demonstrated that SLC29A1 mediates AZA uptake in leukemia cell lines and, importantly, provided mechanistic data linking AZA resistance with lower intracellular concentration of AZA, which is predominantly mediated by reduced expression of SLC29A1 in resistant cells.